Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases, leveraging AI and machine learning to deliver disease-modifying treatments targeting the root causes of debilitating neurological conditions
Brenig Therapeutics is a biotechnology company pioneering the development of innovative small-molecule therapies for neurodegenerative diseases, leveraging AI and machine learning to deliver disease-modifying treatments targeting the root causes of debilitating neurological conditions.